Theratron

Theratron is a brand of radiation therapy equipment used to treat cancer and other diseases. The company, Theratronics International Limited, was founded in 1972 in Saskatoon, Saskatchewan, Canada. Initially, Theratronics focused on designing and manufacturing electron accelerators for industrial and medical applications.

Theratron's radiation therapy equipment is designed to administer precise doses of radiation to cancerous tumors and other affected areas of the body. The company offered a range of machines, including Linear Accelerators (linacs), for cancer treatment.

Theratronics was acquired by Nordion Inc. in 1990, a company that specializes in the production of medical isotopes and radioisotopes for nuclear medicine. After the acquisition, Theratron continued to develop and manufacture radiation therapy equipment under the guidance of Nordion. In 2005, Nordion was acquired by SARS (now part of Mallinckrodt Pharmaceuticals), which continued to develop and support Theratron equipment.

Theratron radiation therapy equipment has been used in hospitals and treatment centers around the world to treat various types of cancer and diseases, including tumors, lymphoma, and melanoma. The company's equipment represented an innovative move towards more precise and targeted radiation therapy.

The Theratron brand and its innovations have had a lasting impact in the field of radiation oncology. The company's leadership in electron linear accelerators for cancer treatment paved the way for advancements in radiation therapy technology and saved countless lives.

In recent years, the brand has continued to evolve under new ownership, with the introduction of advanced cancer treatment technologies. Although the founding company, Theratronics, has undergone significant reorganizations and acquisitions, the Theratron brand remains a recognized name in the medical community.